Abstract
Cancer frequency in muscle-specific kinase myasthenia gravis (MuSK-MG) has not yet been explored and the mechanisms leading to the formation of MuSK IgG remain elusive. We aimed to explore cancer frequency in MuSK-MG patients and to assess MuSK expression in cancer cells from 2 tumors occurred in this cohort. Immunohistochemistry on tumor specimens revealed the expression of MuSK in the cancer cells from primary mediastinal B cell lymphoma and endometrial carcinoma. Twenty-one males and 73 females were enrolled. Fifteen cancers occurred in 13 of 94 patients (13.8%). Patients with cancer were significantly older at time of MuSK-MG onset.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1020-1025 |
| Numero di pagine | 6 |
| Rivista | Annals of Neurology |
| Volume | 96 |
| Numero di pubblicazione | 5 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2024 |
All Science Journal Classification (ASJC) codes
- Neurologia
- Neurologia (clinica)
Keywords
- n/a